CO [China Cord Blood] 6-K: China Cord Blood Corporation Announces Resignation of an

[China Cord Blood Corporation Announces Resignation of an Independent Director HONG KONG, China, May 14, 2015 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that Mr. Julian J. Wolhardt, one of the Company’s independent directors, has resigned] [FORM 6-K Commission Filing Number: 001-34541 CHINA CORD BLOOD CORPORATION 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Description 99.1]

By | 2016-03-27T08:53:44+00:00 May 14th, 2015|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13D/A: (Original Filing)

[Execution Version PURCHASE A GREEMENT THIS PURCHASE A GREEMENT Agreement (this “ BETWEEN : (1) CORDLIFE GROUP LIMITED , a limited liability company incorporated in the Republic of Singapore Seller (the “ (2) GOLDEN MEDITECH HOLDINGS LIMITED , an exempted company with limited liability incorporated in the Cayman Islands and having its principal place of business in Hong Kong at] [Execution Version PURCHASE A GREEMENT THIS PURCHASE A GREEMENT Agreement (this “ May 8 , 2015 BETWEEN : (1) MAGNUM OPUS INTERNATIONAL HOLDINGS LIMITED , a company with limited liability incorporated in the British Virgin Islands Seller (the “ and (2) GOLDEN MEDITECH HOLDINGS LIMITED , an exempted company with limited liability incorporated in the Cayman Islands and having its] []

By | 2016-03-27T08:57:09+00:00 May 8th, 2015|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13D/A: Execution Version PURCHASE A GREEMENT THIS PURCHASE A

[Execution Version PURCHASE A GREEMENT THIS PURCHASE A GREEMENT Agreement (this “ BETWEEN : (1) CORDLIFE GROUP LIMITED , a limited liability company incorporated in the Republic of Singapore Seller (the “ (2) GOLDEN MEDITECH HOLDINGS LIMITED , an exempted company with limited liability incorporated in the Cayman Islands and having its principal place of business in Hong Kong at] [Execution Version PURCHASE A GREEMENT THIS PURCHASE A GREEMENT Agreement (this “ May 8 , 2015 BETWEEN : (1) MAGNUM OPUS INTERNATIONAL HOLDINGS LIMITED , a company with limited liability incorporated in the British Virgin Islands Seller (the “ and (2) GOLDEN MEDITECH HOLDINGS LIMITED , an exempted company with limited liability incorporated in the Cayman Islands and having its] []

By | 2016-03-27T08:58:25+00:00 May 8th, 2015|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13D/A: (Original Filing)

[Execution Version PURCHASE A GREEMENT THIS PURCHASE A GREEMENT Agreement (this “ BETWEEN : (1) CORDLIFE GROUP LIMITED , a limited liability company incorporated in the Republic of Singapore Seller (the “ (2) GOLDEN MEDITECH HOLDINGS LIMITED , an exempted company with limited liability incorporated in the Cayman Islands and having its principal place of business in Hong Kong at] []

By | 2016-03-27T08:59:27+00:00 May 8th, 2015|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 Held by Cordlife and Magnum and its Ordinary Shares Held by Cordlife HONG KONG, China, May 8, 2015 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem] [FORM 6-K Commission Filing Number: 001-34541 CHINA CORD BLOOD CORPORATION 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Description]

By | 2016-03-27T09:02:05+00:00 May 8th, 2015|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Receives Notice of Transactions

[China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 Held by Cordlife and Magnum and its Ordinary Shares Held by Cordlife HONG KONG, China, May 8, 2015 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem] [FORM 6-K Commission Filing Number: 001-34541 CHINA CORD BLOOD CORPORATION 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Description]

By | 2016-03-27T09:03:22+00:00 May 8th, 2015|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13D/A: (Original Filing)

[EXECUTION VERSION PURCHASE AGREEMENT THIS PURCHASE AGREEMENT Agreement BETWEEN: (1) KKR CHINA HEALTHCARE INVESTMENT LIMITED Seller (2) GOLDEN MEDITECH HOLDINGS LIMITED Purchaser Party Parties RECITALS: (A) Notes Company (B) Ordinary Shares NYSE The Notes are convertible into ordinary shares of the Company, par value US$0.0001 per share (the " (C) The Seller intends to sell the Notes to the Purchaser,] [EXECUTION VERSION VOTING DEED THIS VOTING DEED Deed AMONG: (1) Mr. KAM YUEN ( 甘源 ) , Mr. Kam (2) BIO GARDEN INC. Bio Garden") (3) KKR CHINA HEALTHCARE INVESTMENT LIMITED Seller Party Parties RECITALS: (A) Trusts BG Shares Shares Purchaser Bio Garden, a company wholly owned by certain discretionary trusts (" (B) Mr. Kam holds 2,190,278 outstanding share options] [POWER OF ATTORNEY POWER OF ATTORNEY POWER OF ATTORNEY] [Was h i n g t o n , D . C . 2 05 4 9 SCHEDULE 13D (Rule 13d-1 and Rule 13d-2) (Amendment No. 2) CHINA CORD BLOOD CORPORATION (Name of Issuer) Ordinary Shares, par value $0.0001 (Title of Class of Securities) G21107100 (CUSIP Number) David J. Sorkin, Esq. Kohlberg Kravis Roberts & Co. L.P. 9 West 57th]

By | 2016-03-27T09:04:49+00:00 May 4th, 2015|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13D/A: EXECUTION VERSION PURCHASE AGREEMENT THIS PURCHASE AGREEMENT Agreement

[EXECUTION VERSION PURCHASE AGREEMENT THIS PURCHASE AGREEMENT Agreement BETWEEN: (1) KKR CHINA HEALTHCARE INVESTMENT LIMITED Seller (2) GOLDEN MEDITECH HOLDINGS LIMITED Purchaser Party Parties RECITALS: (A) Notes Company (B) Ordinary Shares NYSE The Notes are convertible into ordinary shares of the Company, par value US$0.0001 per share (the " (C) The Seller intends to sell the Notes to the Purchaser,] [EXECUTION VERSION VOTING DEED THIS VOTING DEED Deed AMONG: (1) Mr. KAM YUEN ( 甘源 ) , Mr. Kam (2) BIO GARDEN INC. Bio Garden") (3) KKR CHINA HEALTHCARE INVESTMENT LIMITED Seller Party Parties RECITALS: (A) Trusts BG Shares Shares Purchaser Bio Garden, a company wholly owned by certain discretionary trusts (" (B) Mr. Kam holds 2,190,278 outstanding share options] [POWER OF ATTORNEY POWER OF ATTORNEY POWER OF ATTORNEY] [Was h i n g t o n , D . C . 2 05 4 9 SCHEDULE 13D (Rule 13d-1 and Rule 13d-2) (Amendment No. 2) CHINA CORD BLOOD CORPORATION (Name of Issuer) Ordinary Shares, par value $0.0001 (Title of Class of Securities) G21107100 (CUSIP Number) David J. Sorkin, Esq. Kohlberg Kravis Roberts & Co. L.P. 9 West 57th]

By | 2016-03-27T09:05:44+00:00 May 4th, 2015|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar